Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25498219

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Jan
First author
Grignani G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Jan;16(1):12-3. doi: 10.1016/S1470-2045(14)71186-6.
    note
    Source null
    related pmid
    25638539
    relationship
    Comment in

Authors and identifiers

  1. name
    Grignani G
    type
    Author
  2. name
    Palmerini E
    type
    Author
  3. name
    Ferraresi V
    type
    Author
  4. name
    D'Ambrosio L
    type
    Author
  5. name
    Bertulli R
    type
    Author
  6. name
    Asaftei SD
    type
    Author
  7. name
    Tamburini A
    type
    Author
  8. name
    Pignochino Y
    type
    Author
  9. name
    Sangiolo D
    type
    Author
  10. name
    Marchesi E
    type
    Author
  11. name
    Capozzi F
    type
    Author
  12. name
    Biagini R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Grignani G
    type
    Author
  2. name
    Palmerini E
    type
    Author
  3. name
    Ferraresi V
    type
    Author
  4. name
    D'Ambrosio L
    type
    Author
  5. name
    Bertulli R
    type
    Author
  6. name
    Asaftei SD
    type
    Author
  7. name
    Tamburini A
    type
    Author
  8. name
    Pignochino Y
    type
    Author
  9. name
    Sangiolo D
    type
    Author
  10. name
    Marchesi E
    type
    Author
  11. name
    Capozzi F
    type
    Author
  12. name
    Biagini R
    type
    Author
bibliography ids
  1. nci-bib-2dd6391f4c88b8673c3c5dd9
book metadata
content sha256
4c741ac9b7fa514ebb741e7cc195346e703968b0c0206921e8ee2c149ccf45fe
document type
citation
dois
  1. 10.1016/S1470-2045(14)71136-2
electronic publication date
display
2014 Dec 11
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25498219
immutable id
pubmed:25498219@4c741ac9b7fa514ebb741e7cc195346e703968b0c0206921e8ee2c149ccf45fe
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
98-107
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Jan;16(1):12-3. doi: 10.1016/S1470-2045(14)71186-6.
    note
    Source null
    related pmid
    25638539
    relationship
    Comment in
outcomes validated
false
pmid
25498219
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
291073a40b76b207af0678daf0f8de76ceed389523b47e98a0aadd73dd436abb
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Jan
precision
month
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25498219/
title
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.

Preserved source evidence · Not medical advice